|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Change in fair value of derivative liabilities | |||||
| Impairment of patent | |||||
| Impairment of inventory | |||||
| Amortization of license and patent | |||||
| Change in fair value of derivative liabilities | |||||
| Bad debt | |||||
| Impairment of patent | |||||
| Impairment of inventory | |||||
| Amortization of license and patent | |||||
| Amortization of debt discount | |||||
| Management compensation | |||||
| Loss on settlement of debt | |||||
| Unrealized (gain) loss on investments in marketable securities | |||||
| Depreciation | |||||
| Gain on settlement of debt | |||||
| Changes in operating assets and liabilities: | |||||
| Security deposit | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expense | |||||
| Accounts payable and accrued liabilities | |||||
| Due to related party | |||||
| Net Cash Used in Operating Activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchase property and equipment's | |||||
| Net Cash Used in Investing Activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from issuance for common stock | |||||
| Proceed from related party | |||||
| Repayment to related party | |||||
| Repayment of notes payable - related party | |||||
| Proceeds from issuance of Series D Preferred Stock | |||||
| Proceeds from notes payable | |||||
| Proceeds from convertible notes | |||||
| Net Cash Provided by Financing Activities | |||||
| Net change in cash | |||||
| Cash at beginning of period | |||||
| Cash at end of period | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES | |||||
| Issuance Series A preferred stock for settlement of debt - related party | |||||
| Issuance Series A preferred stock for license fee | |||||
| Issuance Series B preferred stock for license fee | |||||
| Issuance Series B preferred stock for settlement of debt - related party | |||||
| Debts forgiveness - related party | |||||
| Warrant issued for Patent's acquisition | |||||
| Derivative liability recognized as debt discount | |||||
| Issuance of common stock for conversion of debt | |||||
| Issuance of Series A preferred stock for license fee | |||||
| Issuance of Series B preferred stock for license fee | |||||
| Issuance of Series B preferred stock for settlement of debt - related party | |||||
| Issuance of Series C preferred stock for purchase of inventory | |||||
| Issuance of Series C preferred stock for license fee | |||||
| Convertible note issued for consulting service | |||||
| Debt forgiveness | |||||
Loading...